370 related articles for article (PubMed ID: 10967703)
1. [Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis].
Roch-Torreilles I; Camu W; Hillaire-Buys D
Therapie; 2000; 55(2):303-12. PubMed ID: 10967703
[TBL] [Abstract][Full Text] [Related]
2. [Tolerance of riluzole in a phase IIIb clinical trial].
Lacomblez L; Dib M; Doppler V; Faudet A; Robin V; Salachas F; Bensimon G; Meininger V
Therapie; 2002; 57(1):65-71. PubMed ID: 12090150
[TBL] [Abstract][Full Text] [Related]
3. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
4. Effect of riluzole (Rilutek) treatment on plasma amino acid percentages in amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
Neurol Sci; 2003 Nov; 24(4):290-2. PubMed ID: 14658053
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety of riluzole in amyotrophic lateral sclerosis.
Lacomblez L; Bensimon G; Leigh PN; Debove C; Bejuit R; Truffinet P; Meininger V;
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):23-9. PubMed ID: 12061945
[TBL] [Abstract][Full Text] [Related]
6. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Zis V; Sfagos C; Vassilopoulos D
Clin Neurol Neurosurg; 2008 Mar; 110(3):222-6. PubMed ID: 18055102
[TBL] [Abstract][Full Text] [Related]
7. Do the benefits of currently available treatments justify early diagnosis and treatment of amyotrophic lateral sclerosis? Arguments against.
Ludolph AC; Riepe MW
Neurology; 1999; 53(8 Suppl 5):S46-9; discussion S55-7. PubMed ID: 10560638
[TBL] [Abstract][Full Text] [Related]
8. Amyotrophic lateral sclerosis and riluzole use during pregnancy: a case report.
Scalco RS; Vieira MC; da Cunha Filho EV; Lago EG; da Silva IG; Becker J
Amyotroph Lateral Scler; 2012 Sep; 13(5):471-2. PubMed ID: 22670879
[No Abstract] [Full Text] [Related]
9. An acute, life-threatening, hypersensitivity reaction to riluzole.
Sorenson EJ
Neurology; 2006 Dec; 67(12):2260-1. PubMed ID: 17190960
[No Abstract] [Full Text] [Related]
10. What has changed with riluzole?
Meininger V; Lacomblez L; Salachas F
J Neurol; 2000 Dec; 247():19-22. PubMed ID: 11200701
[TBL] [Abstract][Full Text] [Related]
11. [Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)].
Yanagisawa N; Shindo M
Rinsho Shinkeigaku; 1996 Dec; 36(12):1329-30. PubMed ID: 9128396
[TBL] [Abstract][Full Text] [Related]
12. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
[TBL] [Abstract][Full Text] [Related]
13. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
Vucic S; Lin CS; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC
Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
[TBL] [Abstract][Full Text] [Related]
14. Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis.
Stefan K; Kunesch E; Benecke R; Classen J
Ann Neurol; 2001 Apr; 49(4):536-9. PubMed ID: 11310635
[TBL] [Abstract][Full Text] [Related]
15. Reversible granulocytopenia in association with riluzole therapy.
North WA; Khan AM; Yamase HT; Sporn JR
Ann Pharmacother; 2000 Mar; 34(3):322-4. PubMed ID: 10917377
[TBL] [Abstract][Full Text] [Related]
16. Rilutek (Riluzole) may extend survival in amyotrophic lateral sclerosis.
J Neurosci Nurs; 1996 Aug; 28(4):275. PubMed ID: 8880606
[No Abstract] [Full Text] [Related]
17. [Tolerability of riluzole: a review of the literature].
Siniscalchi A
Clin Ter; 2004 Jan; 155(1):25-8. PubMed ID: 15147078
[TBL] [Abstract][Full Text] [Related]
18. [Etiological drug therapy for amyotrophic lateral sclerosis].
Cintas P
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S220-4S227. PubMed ID: 17128115
[TBL] [Abstract][Full Text] [Related]
19. What has changed with riluzole?
Meininger V; Lacomblez L; Salachas F
J Neurol; 2000 Dec; 247 Suppl 6():VI/19-22. PubMed ID: 19714404
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacotherapy of amyotrophic lateral sclerosis].
Jokelainen M
Duodecim; 1997; 113(6):513-6. PubMed ID: 11370073
[No Abstract] [Full Text] [Related]
[Next] [New Search]
